The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.
Violent crypto attacks rise as criminals hunt bigger payouts
Physical attacks targeting cryptocurrency holders surged 33% globally in the first half of 2026, with losses soaring to $124 million. France emerged as the epicentre